CWP
INMB icon

Curated Wealth Partners’s INmune Bio INMB Stock Holding History

Curated Wealth Partners’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+255
New +$353 0.03% 466

Other funds holding INMB

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Curated Wealth Partners's INMB Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in INmune Bio (INMB) in Q2 2026: 255 shares worth $239K. The stake represents 0.03% of the portfolio and ranks #466 among its holdings.

8 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Curated Wealth Partners held 255 shares of INmune Bio worth $239K as of Q2 2026.
  • INmune Bio was a new Curated Wealth Partners position in Q2 2026.
  • INmune Bio made up 0.03% of Curated Wealth Partners's portfolio in Q2 2026, its #466 holding.
  • 8 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.